111, Inc. (YI)

NASDAQ: YI · IEX Real-Time Price · USD
2.77
+0.08 (3.12%)
At close: Mar 24, 2023, 3:59 PM
2.79
+0.02 (0.58%)
After-hours: Mar 24, 2023, 5:35 PM EDT
3.12%
Market Cap 231.03M
Revenue (ttm) 1.94B
Net Income (ttm) -59.81M
Shares Out 83.27M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 44,590
Open 2.64
Previous Close 2.69
Day's Range 2.64 - 2.84
52-Week Range 1.37 - 4.00
Beta 0.93
Analysts Buy
Price Target 6.12 (+120.62%)
Earnings Date Mar 23, 2023

About YI

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vit... [Read more]

Sector Healthcare
Founded 2010
Employees 2,114
Stock Exchange NASDAQ
Ticker Symbol YI
Full Company Profile

Financial Performance

In 2022, 111, Inc.'s revenue was 13.52 billion, an increase of 8.78% compared to the previous year's 12.43 billion. Losses were -416.88 million, -37.76% less than in 2021.

Financial numbers in CNY Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for YI stock is "Buy." The 12-month stock price forecast is $6.12, which is an increase of 120.62% from the latest price.

Price Target
$6.12
(120.62% upside)
Analyst Consensus: Buy
Stock Forecasts

News

111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results

SHANGHAI , March 23, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a...

1 day ago - PRNewsWire

111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow

SHANGHAI , March 2, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...

3 weeks ago - PRNewsWire

111, Inc. Hosts Hua Medicine Launches First Official Flagship Store

SHANGHAI , Feb. 16, 2023 /PRNewswire/ -- On February 15, 2023, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced that during the H...

1 month ago - PRNewsWire

111, Inc. Announces Third Quarter 2022 Unaudited Financial Results

SHANGHAI , Dec. 1, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and ...

4 months ago - PRNewsWire

111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow

SHANGHAI , Nov. 8, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

4 months ago - PRNewsWire

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

SHANGHAI , Sept. 23, 2022 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the...

6 months ago - PRNewsWire

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

SHANGHAI , Sept. 9, 2022 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the ...

7 months ago - PRNewsWire

111, Inc. Announces Second Quarter 2022 Unaudited Financial Results

SHANGHAI , Aug. 25, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...

7 months ago - PRNewsWire

111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow

SHANGHAI , Aug. 5, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

8 months ago - PRNewsWire

111, Inc. Announces First Quarter 2022 Unaudited Financial Results

SHANGHAI , June 16, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...

10 months ago - PRNewsWire

111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow

SHANGHAI, May 26, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and ...

10 months ago - PRNewsWire

111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act

SHANGHAI , May 5, 2022 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that on May 4th, 2022, the Securiti...

11 months ago - PRNewsWire

111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai's Fight Against Covid-19 Pandemic

SHANGHAI , April 13, 2022 /PRNewswire/ -- On April, 2022, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China,  has set up an "Anti-Epidemic Co...

1 year ago - PRNewsWire

111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results

SHANGHAI, March 17, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...

1 year ago - PRNewsWire

111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits

SHANGHAI, March 14, 2022 /PRNewswire/ -- On March 14, 2022, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company signed a strategic cooperation agreement...

1 year ago - PRNewsWire

111, Inc. Reaches Strategic Partnership on Direct Supply with Beilin Pharmaceutical to Blaze New Trails in Digital Development of Chinese Patent Medicine

SHANGHAI, March 4, 2022 /PRNewswire/ -- On February 23, 2022, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, signed a strategic cooperati...

1 year ago - PRNewsWire

111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow

SHANGHAI, Feb. 22, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

1 year ago - PRNewsWire

111, Inc. Announces Third Quarter 2021 Unaudited Financial Results

SHANGHAI, Nov. 19, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

1 year ago - PRNewsWire

111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow

SHANGHAI, Oct. 28, 2021 /PRNewswire/ – 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and ...

1 year ago - PRNewsWire

111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management

SHANGHAI, Oct. 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

1 year ago - PRNewsWire

Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.

Key takeaways: 111's revenue grew 87% in second quarter, generally outpacing its peers, as it aims to more than double its fulfillment capacity this year

1 year ago - Benzinga

111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine an...

1 year ago - PRNewsWire

111, Inc. Announces $10 Million Share Repurchase Program

SHANGHAI, Sept. 7, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

1 year ago - PRNewsWire

111, Inc. Announces Second Quarter 2021 Unaudited Financial Results

SHANGHAI, Aug. 27, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

1 year ago - PRNewsWire

111, Inc. Deepens Partnership with Bayer Healthcare

SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and...

1 year ago - PRNewsWire